WuXi AppTec (OTCMKTS:WUXAY) Hits New 12-Month High – What’s Next?

Shares of WuXi AppTec Co., Ltd. (OTCMKTS:WUXAY) hit a new 52-week high on Wednesday. The company traded as high as $28.6899 and last traded at $28.6899, with a volume of 4909 shares changing hands. The stock had previously closed at $27.67.

Analysts Set New Price Targets

Separately, Zacks Research cut shares of WuXi AppTec from a “strong-buy” rating to a “hold” rating in a research note on Monday. One equities research analyst has rated the stock with a Buy rating and one has given a Hold rating to the company. According to data from MarketBeat.com, WuXi AppTec currently has a consensus rating of “Moderate Buy”.

WuXi AppTec Stock Up 3.7%

The business has a 50 day moving average of $25.10 and a 200-day moving average of $19.86.

About WuXi AppTec

WuXi AppTec is a contract research, development and manufacturing organization (CRDMO) that provides services to pharmaceutical, biotechnology and medical-device companies. Its offerings span the drug-development process, including early-stage discovery, medicinal and synthetic chemistry, biology research, analytical testing, preclinical studies, clinical research support, process development and commercial manufacturing.

The company supports a broad range of therapeutic programs, with capabilities covering small-molecule drugs, biologics, chemical and pharmaceutical products, and cell and gene therapies.